Evonik Industries Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Christian Kullmann

Algemeen directeur

€4.0m

Totale compensatie

Percentage CEO-salaris	34.7%
Dienstverband CEO	10.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	8.5yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Christian Kullmann's beloning veranderd ten opzichte van Evonik Industries's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	€229m
Jun 30 2024	n/a	n/a	-€90m
Mar 31 2024	n/a	n/a	-€356m
Dec 31 2023	€4m	€1m	-€465m
Sep 30 2023	n/a	n/a	-€604m
Jun 30 2023	n/a	n/a	-€295m
Mar 31 2023	n/a	n/a	€272m
Dec 31 2022	€4m	€1m	€539m
Sep 30 2022	n/a	n/a	€926m
Jun 30 2022	n/a	n/a	€944m
Mar 31 2022	n/a	n/a	€869m
Dec 31 2021	€5m	€1m	€748m
Sep 30 2021	n/a	n/a	€724m
Jun 30 2021	n/a	n/a	€642m
Mar 31 2021	n/a	n/a	€546m
Dec 31 2020	€5m	€1m	€489m
Sep 30 2020	n/a	n/a	€614m
Jun 30 2020	n/a	n/a	€617m
Mar 31 2020	n/a	n/a	€679m
Dec 31 2019	€5m	€1m	€753m
Sep 30 2019	n/a	n/a	€506m
Jun 30 2019	n/a	n/a	€624m
Mar 31 2019	n/a	n/a	€673m
Dec 31 2018	€4m	€1m	€686m
Sep 30 2018	n/a	n/a	€841m
Jun 30 2018	n/a	n/a	€797m
Mar 31 2018	n/a	n/a	€788m
Dec 31 2017	€4m	€1m	€713m

Compensatie versus markt: De totale vergoeding ($USD 4.27M ) Christian } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 3.25M ).

Compensatie versus inkomsten: De vergoeding van Christian is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Christian Kullmann (55 yo)

10.3yrs

Tenure

€4,035,000

Compensatie

Mr. Christian Kullmann has been Chairman of Executive Board and Chief Executive Officer of Evonik Industries AG since May 24, 2017 and May 23, 2017 respectively. He served as Deputy Chairman of the Supervi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christian Kullmann	CEO & Chairman of the Executive Board	10.3yrs	€4.04m	geen gegevens
Harald Schwager	Deputy Chairman of the Executive Board	7.2yrs	€3.26m	geen gegevens
Maike Schuh	CFO & Member of Executive Board	1.6yrs	€1.04m	geen gegevens
Thomas Wessel	Chief Human Resources Officer	13.2yrs	€2.22m	geen gegevens
Wilfried Ostendorf	Head of Production and Technology	no data	geen gegevens	geen gegevens
Tim Lange	Head of Investor Relations	no data	geen gegevens	geen gegevens
Thomas Mahlstedt	Vice President M&A	no data	geen gegevens	geen gegevens
Christian Schmid	Head of Corporate Communications	8.5yrs	geen gegevens	geen gegevens
Stefan Mack	Head of the Methionine & Derivatives Product Line	no data	geen gegevens	geen gegevens
Matthias Ruch	Head of External Communications & Corporate Press Officer	no data	geen gegevens	geen gegevens
Gaetano Blanda	Head of Business Line Coating Additives	no data	geen gegevens	geen gegevens
Lauren Kjeldsen	Head of the Smart Materials Division	no data	geen gegevens	geen gegevens

8.5yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 0QDS is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.5 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Bernd Tönjes	Independent Chairman of the Supervisory Board	6.5yrs	€398.00k	geen gegevens
Aldo Belloni	Independent Member of Supervisory Board	7.5yrs	€180.00k	geen gegevens
Werner Fuhrmann	Independent Member of Supervisory Board	3.4yrs	€147.00k	geen gegevens
Michael Rudiger	Independent Member of Supervisory Board	11.7yrs	€237.00k	geen gegevens
Alexandra Krieger	Employee Representative Member of Supervisory Board	2.5yrs	€169.00k	geen gegevens
Angela Titzrath	Independent Member of Supervisory Board	8.5yrs	€158.00k	geen gegevens
Barbara Albert	Independent Member of Supervisory Board	10.3yrs	€137.00k	geen gegevens
Martin Albers	Employee Representative Member of Supervisory Board	9.1yrs	€179.00k	geen gegevens
Martin Kubessa	Employee Representative Member of the Supervisory Board	6.5yrs	€105.00k	geen gegevens
Martina Reisch	Employee Representative Member of Supervisory Board	5.5yrs	€122.00k	geen gegevens
Hussin El Moussaoui	Employee Representative Member of Supervisory Board	4.9yrs	€122.00k	geen gegevens
Alexander Bercht	Employee Representative Deputy Chairman of the Supervisory Board	1.2yrs	€92.00k	geen gegevens

6.5yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0QDS wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

Evonik Industries Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Evonik Industries AG, Annual General Meeting, May 28, 2025

Evonik Industries AG, Annual General Meeting, May 31, 2023

Recent updates

Third quarter 2024 earnings released: EPS: €0.48 (vs €0.21 loss in 3Q 2023)

Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025

Evonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025

Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)

Upcoming dividend of €1.17 per share

First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)

Evonik Industries AG, Annual General Meeting, May 28, 2025

Full year 2023 earnings released: €1.00 loss per share (vs €1.16 profit in FY 2022)

International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.

Lanxess Reportedly Seeks to Sell Polyurethane Ops

Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)

Second quarter 2023 earnings released: €0.58 loss per share (vs €0.64 profit in 2Q 2022)

Evonik Industries AG to Report Q1, 2024 Results on May 08, 2024

Evonik Industries AG Revises Financial Guidance for the Full Year 2023

RAG Stiftung Not in Hurry to Cut Evonik Stake

Upcoming dividend of €1.17 per share at 5.8% yield

First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022)

Full year 2022 earnings released: EPS: €1.16 (vs €1.61 in FY 2021)

SABO S.p.A. acquired TAA derivatives business from Evonik Industries AG (XTRA:EVK).

Third quarter 2022 earnings released: EPS: €0.46 (vs €0.49 in 3Q 2021)

Kensing, LLC completed the acquisition of Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK).

Evonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023

Second quarter 2022 earnings released: EPS: €0.64 (vs €0.48 in 2Q 2021)

Kensing, LLC entered into an agreement to acquire Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK)

Kensing, LLC entered into an agreement to acquire Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK)

Evonik Industries AG, Annual General Meeting, May 31, 2023

Upcoming dividend of €1.17 per share

First quarter 2022 earnings released: EPS: €0.67 (vs €0.41 in 1Q 2021)

Evonik Industries AG Provides Earnings Guidance for the Full Year 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023

Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020)

Evonik Industries AG (XTRA:EVK) acquired JeNaCell GmbH.

Orion Engineered Carbons S.A. Settles Dispute with Evonik Industries AG

Upcoming dividend of €1.15 per share

First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020)

Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam

Full year 2020 earnings released

Revenue beats expectations

New 90-day high: €28.06

Evonik Industries AG to Report Q4, 2020 Results on Mar 04, 2021

New 90-day high: €27.33

New 90-day high: €27.32

Evonik Industries AG (XTRA:EVK) completed the acquisition of LACTEL Absorbable Polymer Product Line of DURECT Corporation (NasdaqCM:DRRX) for $15 million.

New 90-day high: €26.62

Evonik Industries AG to Report Q2, 2021 Results on Aug 05, 2021

New 90-day high: €25.18

Evonik Industries AG to Report Q3, 2021 Results on Nov 04, 2021

Third quarter 2020 earnings released: EPS €0.32

Revenue beats expectations

New 90-day low: €21.91

New 90-day low: €22.29

Evonik Industries AG (XTRA:EVK) entered into a definitive agreement to acquire Porocel Corporation for $210 million.

New 90-day high - €25.25

First half earnings released

Evonik Industries AG (XTRA:EVK) completed the acquisition of Innovativehealth Group,s.l

United Initiators GmbH completed the acquisition of Hydrogen Peroxide (H2O2) plant of Evonik Industries AG (XTRA:EVK).

New 90-day high - €25.22

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd